Molecular mechanisms for tumour resistance to chemotherapy

ST Pan, ZL Li, ZX He, JX Qiu… - Clinical and Experimental …, 2016 - Wiley Online Library
Chemotherapy is one of the prevailing methods used to treat malignant tumours, but the
outcome and prognosis of tumour patients are not optimistic. Cancer cells gradually …

Advances in sarcoma gene mutations and therapeutic targets

P Gao, NA Seebacher, F Hornicek, Z Guo… - Cancer treatment …, 2018 - Elsevier
Sarcomas are rare and complex malignancies that have been associated with a poor
prognostic outcome. Over the last few decades, traditional treatment with surgery and/or …

Primary cardiac angiosarcoma: a case report

X Fang, S Zheng - Journal of International Medical Research, 2021 - journals.sagepub.com
Primary cardiac angiosarcoma is relatively rare, and most cases involve metastasis at the
time of diagnosis. The median survival time is 14 months for patients who can be treated …

The cell uptake properties and hyperthermia performance of Zn0.5Fe2.5O4/SiO2 nanoparticles as magnetic hyperthermia agents

R Wang, J Liu, Y Liu, R Zhong, X Yu… - Royal Society …, 2020 - royalsocietypublishing.org
Zn0. 5Fe2. 5O4 nanoparticles (NPs) of 22 nm are synthesized by a one-pot approach and
coated with silica for magnetic hyperthermia agents. The NPs exhibit superparamagnetic …

[HTML][HTML] Poly (ethylene glycol)-sheddable reduction-sensitive polyurethane micelles for triggered intracellular drug delivery for osteosarcoma treatment

Z Yang, Q Guo, Y Cai, X Zhu, C Zhu, Y Li, B Li - Journal of Orthopaedic …, 2020 - Elsevier
Background The survival rate of osteosarcoma therapy still lags behind overall cancer
therapies due to the intrinsic or acquired drug resistance. Developing novel drug delivery …

Pazopanib and trametinib as a synergistic strategy against osteosarcoma: Preclinical activity and molecular insights

G Chiabotto, G Grignani, M Todorovic, V Martin… - Cancers, 2020 - mdpi.com
Receptor tyrosine kinases (RTKs) inhibitors' activity in advanced osteosarcoma is significant
but short-lived. To prevent or at least delay drug resistance, we explored a vertical inhibition …

Euphorbia lunulata extract acts on multidrug resistant gastric cancer cells to inhibit cell proliferation, migration and invasion, arrest cell cycle progression, and induce …

Z Fu, X Han, J Du, X Han, W Liu, S Shao… - Journal of …, 2018 - Elsevier
Ethnopharmacological relevance The milky sap or the aboveground part of the plant
Euphorbia lunulata has long been used by Chinese people to treat noncancerous growths …

A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibrosarcomatous dermatofibrosarcoma protuberans and harboring an EML4 …

N Olson, O Rouhi, L Zhang, C Angeles… - Journal of cutaneous …, 2018 - Wiley Online Library
A subset of soft tissue sarcomas often harbors recurrent fusions involving protein kinases.
While some of these fusion events have shown utility in arriving at a precise diagnosis, novel …

Research Progress on Chemical Constituents and Anticancer Pharmacological Activities of Euphorbia lunulata Bunge

Y Wang, X Yu, L Wang, F Zhang… - BioMed Research …, 2020 - Wiley Online Library
Euphorbia lunulata Bunge (ELB) is a traditional Chinese medicine possessing the functions
of expectoration, cough relief, asthma relief, detoxification, and itching relief. Modern …

Transcriptome and Functional Genomics Reveal the Participation of Adenine Phosphoribosyltransferase in Trypanosoma cruzi Resistance to Benznidazole

P García‐Huertas, AM Mejía‐Jaramillo… - Journal of Cellular …, 2017 - Wiley Online Library
Currently, the only available treatments for Trypanosoma cruzi are benznidazole (Bz) and
nifurtimox (Nfx). The mechanisms of action and resistance to these drugs in this parasite are …